Larimar Therapeutics (LRMR) Q4 2024 Earnings

Oct 30Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.37
-0.33
-0.28
-0.24

Details

Expected EPS
-0.374716
Actual EPS
-0.24
Surprise EPS
0.13
Surprise Percent
+35.95%

Description

⁨Larimar Therapeutics⁩ (⁦LRMR⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts